Showing results (11-20 of 66) with videos related to
Sort By:
Pageof 7
Diabetes & Metabolism|August 3, 2010
Physical exercise for the prevention and treatment of type 2 diabetesC Sanz, J-F Gautier, H HanaireDiabetes & Metabolism|May 21, 1999
Development of beta 3-adrenoceptor agonists for the treatment of obesity and diabetes--an updateC Weyer, J F Gautier, E DanforthDiabetes & Metabolism|July 22, 2008
Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetesJ-F Gautier, S-P Choukem, J GirardDiabetes & Metabolism|September 6, 2005
Is capillary ketone determination useful in clinical practice? In which circumstances?T Meas, P Taboulet, E Sobngwi, et al.Diabetes & Metabolism|May 15, 2003
Marital status and family size of type 1 diabetic patients in a French cohortE Sobngwi, H Leblanc, P Vexiau, et al.Diabetes & Metabolism|December 15, 2010
Diabetes mellitus and glucose-6-phosphate dehydrogenase deficiency: from one crisis to anotherC Carette, D Dubois-Laforgue, J-F Gautier, et al.Diabetes & Metabolism|September 6, 2005
Biological actions of the incretins GIP and GLP-1 and therapeutic perspectives in patients with type 2 diabetesJ F Gautier, S Fetita, E Sobngwi, et al.Annales Francaises D'Anesthesie Et De Reanimation|September 4, 2004
[French residents in anaesthesia and critical care - a nationwide survey]J-F Gautier, J-L N'Guyen, C Soltner, et al.Diabetes & Metabolism|December 3, 2014
Incretin-based therapy and pancreatic beta cellsS Chon, J-P Riveline, B Blondeau, et al.European Journal of Endocrinology|October 31, 2003
Absence of exercise-induced variations in adiponectin levels despite decreased abdominal adiposity and improved insulin sensitivity in type 2 diabetic menP Boudou, E Sobngwi, F Mauvais-Jarvis, et al.Pageof 7